Searched for
BAYER PHARMACEUTICALS
Alembic Pharma gets USFDA tentative nod for generic prostate cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate c...- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Amazon signs $30 million deal to buy carbon credits from Indian rice farmersAmazon has signed a $30 million (around ₹280 crore) agreement with the Good Rice Alliance, backed by Bayer, Temasek’s GenZero and Shell, to...
- Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
- Bayer gets nod to market Kerendia for heart failure treatmentBayer has secured approval in India for its therapy Kerendia to treat heart failure. This drug, finerenone, is already used for chronic kid...
- Bayer seeks approval for key heart drug in IndiaPharmaceutical major Bayer has filed for Indian approval of its patented drug finerenone (Kerendia) to treat heart failure patients with LV...
- Bayer acquires remaining 25% stake in Bayer Zydus Pharma Pvt Ltd to secure full ownershipBayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited have concluded their joint venture, Bayer Zydus Pharma Private Limited...
- German pharma major Bayer stops business in Pakistan: ReportBayer, one of the world's biggest pharmaceutical firms, is closing its business in Pakistan in the wake of a protest from local employees w...
- Bayer steps up India R&D, clinical trials"Our strategy for India in pharmaceuticals is to continue to make significant investments, we believe that India is a growing market with a...
- Bill Anderson to become new CEO of BayerBill Anderson is set to take charge as the CEO of Bayer.
- Bayer Pharmaceuticals committed to India growth; to push for more R&D"Asia Pacific is the fastest growing region for Bayer's pharmaceuticals sales globally. We are very interested and committed to India and a...
- Alembic gets tentative USFDA nod for erectile dysfunction drugAccording to IMS December 2016 data, vardenafil hydrochloride tablets had an estimated market size of USD 9.5 million.
- Sun Pharmaceuticals among bidders for Bayer’s dermatology brandsPrivate equity players KKR, Nordic Capital, Bain Capital, Blackstone and Cinven may also be looking at buying the same assets.
- Bayer CropScience appoints Pankaj Patel as chairmanBayer CropScience informed that the board appointed Pankaj Patel as an additional non-executive director of the company with effect from Ju...
- Fulford India divests consumer care biz to Bayer Pharmaceuticals Private LtdBayer will completely take over the marketing and distribution of the consumer care products with effect from January 1, 2015, it added.
- Bayer challenges IPAB’s compulsory licence order to Natco Pharma on cancer drug Nexavar“We introduce the product after years of research and investment, while companies like Natco merely copy and manufacture the product,” said...
- Bayer set to sell off Powai HQ for over Rs 90 croreLocated a stone’s throw from the Colgate headquarters, the six-storey building’s sale, to be finalized soon, is estimated to fetch Bayer ov...
- Pharma industry split over nod to Natco to sell Bayer's cancer drugThe decision to allow Natco Pharma to sell Bayer's patented cancer drug Nexavar has divided the pharmaceutical industry.
- Bayer AG expects India sales to double by 2015Bayer AG said it expects sales in India to double by 2015 and targets more than 60% increase in revenue from entire Asia during the period
- Bayer group to sell diagnostics biz to SiemensMultinational healthcare and pharmaceutical major Bayer Group on Friday said it is planning to sell its diagnostics business to Siemens AG,...
Load More
